Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock-inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors.


Journal

HIV medicine
ISSN: 1468-1293
Titre abrégé: HIV Med
Pays: England
ID NLM: 100897392

Informations de publication

Date de publication:
12 2022
Historique:
received: 26 07 2022
accepted: 15 09 2022
pubmed: 20 10 2022
medline: 3 12 2022
entrez: 19 10 2022
Statut: ppublish

Résumé

HIV late presentation (LP) has been increasing in recent years in Europe. Our aim was to investigate the characteristics of LP in Greece using in addition to the traditional definition for LP, the time interval between HIV infection and diagnosis. Our nationwide sample included HIV-1 sequences generated from 6166 people living with HIV (PLWH) in Greece during the period 1999-2015. Our analysis was based on the molecularly inferred HIV-1 infection dates for PLWH infected within local molecular transmission clusters of subtypes A1 and B. Analysis of the determinants of LP was conducted using either CD4 counts or AIDS-defining condition at diagnosis or the time from infection to diagnosis. Older age, heterosexual transmission risk group and more recent diagnosis were associated with increased risk for LP. In contrast to previous studies, people who inject drugs (PWID) had a shorter median time to diagnosis (0.63 years) compared to men who have sex with men (MSM) (1.72 years) and heterosexuals (2.43 years). Using HIV infection dates that provide an unbiased marker for LP compared to CD4 counts at diagnosis, which are age-dependent, we estimated that the time to diagnosis increased gradually with age. Migrants infected regionally do not differ with respect to LP status compared to native Greeks. We demonstrate that older people and heterosexuals are among those at higher risk for LP; and given the growing number of older people among newly diagnosed cases, tailored interventions are needed in these populations.

Identifiants

pubmed: 36258653
doi: 10.1111/hiv.13415
pmc: PMC10092532
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1143-1152

Informations de copyright

© 2022 The Authors. HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association.

Références

AIDS Res Hum Retroviruses. 2021 Nov;37(11):846-851
pubmed: 33461392
J Int AIDS Soc. 2015 Nov 18;18:20317
pubmed: 26584954
Pathogens. 2021 Jul 02;10(7):
pubmed: 34357985
Addiction. 2015 Sep;110(9):1453-67
pubmed: 26032121
BMC Public Health. 2016 Aug 25;16(1):878
pubmed: 27557878
HIV Med. 2022 Dec;23(11):1143-1152
pubmed: 36258653
Euro Surveill. 2021 Nov;26(47):
pubmed: 34823639
Viruses. 2020 Oct 19;12(10):
pubmed: 33086773
HIV Med. 2023 Jan;24(1):75-81
pubmed: 35662378
Sci Rep. 2016 Dec 05;6:38100
pubmed: 27917890
Infect Genet Evol. 2021 Jul;91:104799
pubmed: 33677110
AIDS Care. 2014;26 Suppl 1:S83-93
pubmed: 24731147
Antivir Ther. 2011;16(7):1103-12
pubmed: 22024526
Genitourin Med. 1996 Feb;72(1):27-31
pubmed: 8655163
HIV Med. 2012 Mar;13(3):172-81
pubmed: 22093171
J Int AIDS Soc. 2012 Oct 11;15(2):17395
pubmed: 23305650
HIV Med. 2011 Jan;12(1):61-4
pubmed: 20561080
Int J STD AIDS. 2012 Jul;23(7):475-80
pubmed: 22844000
Lancet HIV. 2022 Apr;9(4):e269-e280
pubmed: 35218732
J Infect Dis. 2011 Oct 1;204(7):1095-103
pubmed: 21881125
Clin Infect Dis. 2013 Mar;56(6):888-97
pubmed: 23223594
Subst Abuse Treat Prev Policy. 2022 Feb 10;17(1):11
pubmed: 35144631
Viruses. 2022 Jan 06;14(1):
pubmed: 35062305
Sci Rep. 2018 Jun 5;8(1):8594
pubmed: 29872068

Auteurs

Evangelia Georgia Kostaki (EG)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Stefanos Limnaios (S)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Georgios Adamis (G)

1st Department of Internal Medicine, G. Gennimatas General Hospital, Athens, Greece.

Georgios Xylomenos (G)

1st Department of Internal Medicine, G. Gennimatas General Hospital, Athens, Greece.

Maria Chini (M)

3rd Department of Internal Medicine-Infectious Diseases Unit, "Korgialeneio-Benakeio" Red Cross General Hospital, Athens, Greece.

Nikos Mangafas (N)

3rd Department of Internal Medicine-Infectious Diseases Unit, "Korgialeneio-Benakeio" Red Cross General Hospital, Athens, Greece.

Marios Lazanas (M)

3rd Department of Internal Medicine-Infectious Diseases Unit, "Korgialeneio-Benakeio" Red Cross General Hospital, Athens, Greece.

Stavros Patrinos (S)

National Public Health Organization, Athens, Greece.

Simeon Metallidis (S)

1st Department of Internal Medicine, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Olga Tsachouridou (O)

1st Department of Internal Medicine, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Vasileios Papastamopoulos (V)

5th Department of Internal Medicine and Infectious Diseases, Evaggelismos General Hospital, Athens, Greece.

Dimitrios Chatzidimitriou (D)

National AIDS Reference Centre of Northern Greece, Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Anastasia Antoniadou (A)

4th Department of Medicine, Attikon General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Antonios Papadopoulos (A)

4th Department of Medicine, Attikon General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Konstantinos Protopapas (K)

4th Department of Medicine, Attikon General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Chrysa Tsiara (C)

National Public Health Organization, Athens, Greece.

Mina Psichogiou (M)

1st Department of Medicine, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Dimitrios Basoulis (D)

1st Department of Medicine, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Dimitrios Pilalas (D)

National AIDS Reference Centre of Northern Greece, Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Dimitra Paraskeva (D)

Department of Internal Medicine, Tzaneio General Hospital, Piraeus, Greece.

Georgios Chrysos (G)

Department of Internal Medicine, Tzaneio General Hospital, Piraeus, Greece.

Vasileios Paparizos (V)

HIV/AIDS Unit, A. Syngros Hospital of Dermatology and Venereology, Athens, Greece.

Sofia Kourkounti (S)

HIV/AIDS Unit, A. Syngros Hospital of Dermatology and Venereology, Athens, Greece.

Helen Sambatakou (H)

HIV Unit, 2nd Department of Internal Medicine, Hippokration General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Vasileios Bolanos (V)

HIV Unit, 2nd Department of Internal Medicine, Hippokration General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Nikolaos V Sipsas (NV)

Department of Pathophysiology, Laikon General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Malvina Lada (M)

2nd Department of Internal Medicine, Sismanogleion General Hospital, Athens, Greece.

Emmanouil Barbounakis (E)

Department of Internal Medicine, University Hospital of Heraklion "PAGNI", Medical School, University of Crete, Heraklion, Greece.

Evrikleia Kantzilaki (E)

Department of Internal Medicine, University Hospital of Heraklion "PAGNI", Medical School, University of Crete, Heraklion, Greece.

Periklis Panagopoulos (P)

Department of Internal Medicine, University General Hospital, Democritus University of Thrace, Alexandroupolis, Greece.

Vasilis Petrakis (V)

Department of Internal Medicine, University General Hospital, Democritus University of Thrace, Alexandroupolis, Greece.

Stelios Drimis (S)

Department of Internal Medicine, Tzaneio General Hospital, Piraeus, Greece.

Ioannis Katsarolis (I)

Medical Affairs, Gilead Sciences Hellas, Athens, Greece.

Pagona Lagiou (P)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Angelos Hatzakis (A)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Gkikas Magiorkinis (G)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Lemonia Skoura (L)

National AIDS Reference Centre of Northern Greece, Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Dimitrios Paraskevis (D)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH